Social Media Ideas for Lynch Regenerative Medicine

<![CDATA[Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform]]>

Regenerative Medicine Innovations Shaping The Future Of Healthcare

Healthcare looks different today than it did a decade ago. Patients now expect treatments that support recovery, reduce long-term complications, and improve quality of life. Resear...

Joseph Spine Institute Announces New Regenerative Therapy Center, Offering Advanced Adipose-Derived Cell and PRP Therapi...

TAMPA, Fla., Sept. 3, 2026 /PRNewswire/ — Joseph Spine Institute, a nationally recognized leader in advanced spine care and minimally invasive…

Could a Growth Factor Help Complex Wounds Heal Faster After Skin Cancer Surgery?

Enrollment is complete in a phase 2 trial investigating the use of pure PDGF as an adjunctive therapy for complex surgical wounds following skin cancer excision.

Tampa General Hospital Secures Funding to Establish Center for Lymphatic Education and Research

Backed by new funding through the University of South Florida, the Center for Lymphatic Education and Research will unite clinicians, scientists and educators to advance treatment,...

Denver Regenerative Medicine Publishes Patient-Education Materials Defining "Rejuvenation Therapy"

Regenerative Medicine in the Bronze Age: MSCs and MSC-EVs Leading the Way

The field of regenerative medicine is gaining momentum. Mesenchymal stem cells (MSCs) remain central to this field, with expanding applications as direct therapies and as producers...

Las Vegas company grows patients’ skin in lab to treat severe burns

Regenicin, a biotech company at Roseman (University) Bioventures, can take a small piece of skin from a burn patient and grow it in the lab into a piece up to 100 times larger in a...

Repligen: Acquisition To Add Cell Therapy Capabilities

Could Tissue Restoration Be the Next Step in Regenerative Aesthetics?

Research into the extracellular matrix is exploring new approaches to restoring soft tissue, with potential applications ranging from facial rejuvenation to post-weight-loss restor...

Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy

Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1)

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Vivex Biologics Launches VIA Linxâ„¢, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advan...

New molecular medical device joins Vivex's growing suite of allograft and advanced wound care technologies.

Human Biological Datacenter to Launch to Train World Model of Human Biology

Vivodyne confirms that it grows over 20 types of different human organ tissues, both healthy and with patient-linked diseases, including liver, lungs, gut, bone marrow, pancreas, k...

Dr. Malda Al Daoudi

Rejuran: Advancing Regenerative Aesthetics Through Skin Healing and Rejuvenation As regenerative medicine continues to shape the future of aesthetic dermatology, treatments that st...

Six MASH biotech companies shaping the future of liver disease treatment

Discover six MASH companies to keep an eye on as the race to shape the next generation of liver disease therapies heats up. The post Six MASH biotech companies shaping the future o...

OncoLens' AI-Powered Analytics Platform Helps Large Academic Cancer Center in Florida Cut Referral Delays and Surface Ca...

Case study finds nearly 9 in 10 actionable cancer data points existed only in unstructured text invisible to standard EMR reporting; OncoLens Analytics helped the center lift on-ti...

Timing Regenerative Signals Determines Healing Outcomes After Injury

Medicine has long aimed to deliver the right therapeutic signals to the right tissue at the right moment. New University of Oregon research suggests that regenerative outcomes may...

Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings

The FDA has put a clinical hold on Regenxbio’s RGX-121 over asymptomatic spine MRI findings, derailing the biotech’s plans to refile for approval of the once-rejected gene therapy...

From France to the OR: LARS Technology Makes Its U.S. Debut

250,000 implants, 36 countries and more than 100 peer reviewed papers supporting the LARS® and it is ONLY now making its U.S. debut.

Exosomes From Stem Cells Fight Liver Disease in Mice

Researchers have described a method of using exosomes derived from mesenchymal stem cells (MSCs) to fight harmful metabolic changes in the liver. Another look […]

Restorative Spine Center of NY Launches Boutique Destination for Advanced Minimally Invasive and Restorative Spine Care

From left to right: Dr. Justin B. Ledesma, Dr. Daniel Choi, and Dr. Courtney Toombs, the fellowship-trained spine…

Enlivex Receives FDA RMAT Designation For Osteoarthritis Immunotherapy Allocetraâ„¢

A clinical-stage immunotherapy designed to tackle one of the world’s most common age-related conditions has received a significant regulatory boost... The post Enlivex Receives FDA...

MYOLYN and Brooks Rehabilitation Formalize Decade-Long Collaboration to Drive the Next Generation of Rehabilitation

Newly structured partnership will accelerate patient-centered device development, clinical research, and expanded access for people living with neurological injuries or illness. GA...